Effectiveness of Self-Management Skills for Metabolic Syndrome Fatty Liver Disease Adults

Sponsor
Chang Gung University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT05472298
Collaborator
Chang Gung Memorial Hospital (Other)
137
1
2
24
5.7

Study Details

Study Description

Brief Summary

The multidimensional self-management intervention program focusing on healthy dietary habit and exercise effectively prevents metabolic syndrome. Thus, the purpose of this study was to assess the efficacy of multidimensional self-management intervention program on metabolic syndrome subjects in Taiwan.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: self-management intervention
N/A

Detailed Description

The study is a 2-parallel groups' randomized controlled trial. Participants with metabolic syndrome (three or more risk factors - triglycerides (TG) >150 mg/dL, systolic blood pressure (SBP) ≥130 mm Hg, diastolic blood pressure (DBP) ≥85 mm Hg, or fasting blood glucose≥100 mg/dL; high-density lipoprotein cholesterol<50 mg/dL, or waist circumference ≥80 cm) are enrolled. The four community units are randomized to receive a lifestyle intervention (intervention arm) or an education leaflet (control arm). The parameters are obtained from physical examination and biochemical assessments by well-trained case manager at baseline and each follow visit (6th months and 18th months). All participants complete a structured questionnaire, including basic information, physical activity, and food-frequency.

Study Design

Study Type:
Interventional
Actual Enrollment :
137 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
The Effectiveness of Self-Management Skills and Technology in Individuals Who Have Both Metabolic Syndrome in Community
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Jul 31, 2019
Actual Study Completion Date :
Jul 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention arm

lifestyle modification, goal setting, coaching and peer support, problem-solving, and self-monitoring

Behavioral: self-management intervention
lifestyle modification, goal setting, coaching and peer support, problem-solving

No Intervention: control arm

education leaflet

Outcome Measures

Primary Outcome Measures

  1. metabolic syndrome [6 month, and 18-month follow up]

    changes in triglycerides, high-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, fasting blood glucose, waist circumference

Secondary Outcome Measures

  1. body weight [6 months, and 18 months follow up]

    weight in kilograms

  2. BMI [6 months, and 18 months follow up]

    weight and height will be combined to report BMI in kg/m^2

Other Outcome Measures

  1. leisure-time physical activity [6 months, and 18 months follow up]

    moderate-vigorous leisure-time physical activity at least 150 minutes a week

  2. dietary behaviors [6 months, and 18 months follow up]

    intake rate of whole grains, vegetables, fruits, proteins, dairy products, and nuts.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adult women with age ≥ 50 years

  • low education, defined as having less than 6 years of education or being primary school graduates

  • presence of metabolic syndrome

  • community-dwelling

  • no hearing and visual acuity difficulties

Exclusion Criteria:
  • Unconscious

  • Cognitive impairment or dementia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taoyuan Taoyuan Taiwan

Sponsors and Collaborators

  • Chang Gung University of Science and Technology
  • Chang Gung Memorial Hospital

Investigators

  • Principal Investigator: Shu-Hung Chang, Ph. D, Chang Gung University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shu-Hung Chang, Professor, Chang Gung University of Science and Technology
ClinicalTrials.gov Identifier:
NCT05472298
Other Study ID Numbers:
  • MOST 107-2314-B-255-006
First Posted:
Jul 25, 2022
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shu-Hung Chang, Professor, Chang Gung University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022